July 30, 2012Pharma Newsadmin BUFFALO, N.Y. -- Cleveland BioLabs, Inc. today announced that, through a wholly-owned Russian subsidiary, it has signed a contract valued at 139 million rubles, or approximately $4 million (based on current ...
